BMO starts Ironwood at Market Perform

|About: Ironwood Pharmaceuticals, Inc. (IRWD)|By:, SA News Editor

Not everyone is overly concerned with downside to Linzess estimates, despite downbeat commentary from Goldman and Mizuho.

BMO initiates Ironwood Pharmaceuticals (IRWD) at Market Perform.

Price target is $15, well above Goldman's $9.50 objective.